search
Back to results

The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy

Primary Purpose

Vital Signs, Anxiety, Colonoscopy

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
virtual reality glasses
Sponsored by
Esra DOĞAN YILMAZ, RN, MSc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Vital Signs focused on measuring Anxiety, colonoscopy, pain, virtual reality glasses, vital signs

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Voluntary
  • Scheduled for a colonoscopy without sedation
  • Aged 18 to 79 years
  • No perception, hearing, and vision impairment that interferes with communication
  • Not wearing glasses
  • No psychiatric disorder
  • No migraine, vertigo, active nausea, vomiting, headache, etc.

Exclusion Criteria:

  • no Voluntary
  • Scheduled for a colonoscopy with sedation
  • not been Aged 18 to 79 years
  • participants have been perception, hearing, and vision impairment that interferes with communication
  • wearing glasses
  • participants have psychiatric disorder
  • participants have migraine, vertigo, active nausea, vomiting, headache, etc.

Sites / Locations

  • Kirikkale University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

intervention

control

Arm Description

This study was carried out with two groups. Virtual reality glasses were used for the intervention group.

No application was made to the control group, standard procedure was followed.

Outcomes

Primary Outcome Measures

blood pressure
mmHg. higher scores mean a worse
pulse rate (heart rate)
beats per minute. higher scores mean a worse
respiratory rate
respiratory rate per minute. higher scores mean a worse
peripheral oxygen saturation (SpO2)
Approaching 100% is considered positive. higher scores mean a better
Pain score
Visual Analog Scale-Pain (VAS-P), which is a 10cm long line with anchor statements "0=no pain" at the left-most end and "10=unbearable pain" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better
Anxiety score
Visual Analog Scale-Anxiety (VAS-A), which is a 10 cm long horizontal line with anchor statements "0=no anxiety at all" at the left-most end and "10=worst anxiety imaginable" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better

Secondary Outcome Measures

Full Information

First Posted
July 15, 2021
Last Updated
August 24, 2021
Sponsor
Esra DOĞAN YILMAZ, RN, MSc
search

1. Study Identification

Unique Protocol Identification Number
NCT05027659
Brief Title
The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy
Official Title
The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
January 2, 2020 (Actual)
Primary Completion Date
September 28, 2020 (Actual)
Study Completion Date
December 20, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Esra DOĞAN YILMAZ, RN, MSc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The present study was conducted with 44 patients who applied to the Endoscopy Unit of a university hospital for sedation-free colonoscopy between January 2, 2020 and September 28, 2020, met the inclusion criteria and agreed to participate in the study. The patients were homogeneously divided into experimental (n=22) and control (n=22) groups based on their gender and history of colonoscopy. The patients in the experimental group watched a 360 degree virtual reailty (VR) video with atmospheric background music over images and sounds of nature through virtual reality glasses while no application was performed for the patients in the control group during the procedure. The "Demographic Information Form", "Trait Anxiety Scale", "Visual Analog Scale-Pain", "Visual Analog Scale-Anxiety", "Vital Signs Monitoring Chart" and "Satisfaction Evaluation on the Virtual Reality Glasses Application" forms were used in the data collection phase. For the study, an ethics committee approval was obtained in addition to written consent by the institutions and patients. Numbers, percentages, the Chi-square test, the Wilcoxon test and the Mann-Whitney U test were used for data analysis.
Detailed Description
Aims: This study investigated the effect of VR glasses on vital signs and anxiety in patients undergoing colonoscopy. The research questions are as follows: Wearing VR glasses during colonoscopy affects at least one vital sign. Wearing VR glasses during colonoscopy affects anxiety. Study design and setting: This study adopted a randomized controlled experimental design. The study population consisted of all patients (N=82) who had a colonoscopy without sedation between January 2, 2020, and September 28, 2020, at the endoscopy unit of a training and research hospital in Kırıkkale, Turkey. Patients were randomized into experimental and control groups before the procedure. Group 1 (experimental): Virtual reality glasses have a detachable screen frame compatible with smartphones. A VR headset has earphones and sensors that track the user's head movements, giving them the impression that they are moving around in a virtual environment (Arane et al., 2017; Indovina et al., 2018). The investigators used a smartphone and VR glasses to perform the intervention. They connected the phone to the VR headset via a 360o VR video app. Experimental participants wore the VR glasses and watched a 360o VR video of nature scenes with ambiance music during colonoscopy. They put on the VR glasses right before the procedure and took them off right afterward. Each control group participant (Group 2) underwent the standard procedure. Sample size calculation: The sample consisted of 44 participants divided into experimental (n=22) and control (n=22). A post-power analysis was conducted on Visual Analog Scale-Pain (VAS-P) scores due to the pandemic. The results showed that the sample was large enough to detect significant differences (effect size = 1.31; type I margin of error (α) = 0.05; test power (1-β) = 0.98). Randomization: Simple stratified randomization was used for homogeneity.Participants were assigned to the groups based on their gender and colonoscopy history.For each patient randomly assigned to a group (drawing lots), another patient with the same gender and colonoscopy history was included in the other group. For example, the investigators wrote down "experimental" and "control" on pieces of paper for a female participant scheduled for a colonoscopy for the first time and put them in a bag. Then, they asked the nurse in charge to pull one of the pieces of paper out of the bag. In this way, that participant was assigned to the group written on the piece of paper. Afterward, the investigators assigned another patient with the same gender and colonoscopy history to the other group. The nurse pulled a new piece of paper out of the bag for a patient with a different gender and colonoscopy history. The investigatorsassigned that patient to the corresponding group. They followed the same procedure for all groups (Woman-first time colonoscopy; Woman- colonoscopy before; Man-first time colonoscopy; Man- colonoscopy before) to achieve homogenous groups. Research shows that gender and colonoscopy history affect pain and anxiety during colonoscopy. Therefore, the investigators used the same parameters to randomize participants into the groups, which were similar in terms of gender and colonoscopy history. Data collection tools: Data were collected using a demographic characteristics questionnaire and the Visual Analog Scale-Anxiety (VAS-A). Vital signs (Blood pressure, pulse rate, and SpO2) were also measured using a monitor. The respiratory rate was measured by the researcher. The pain was assessed using the Visual Analog Scale-Pain (VAS-P). A five-point scale ("very satisfied,""satisfied,""undecided,""dissatisfied," and "very dissatisfied") was used to determine how satisfied participants were with wearing the VR glasses during the procedure. Research Implementation: Patients were informed about the research purpose and procedure, and consent was obtained from those who agreed to participate. All participants filled out the demographic characteristics questionnaire, VAS-P, and VAS-A, and their vital signs were measured before colonoscopy. The experimental group participants wore the VR glasses and watched a 360 degree VR video of nature scenes with ambiance music during colonoscopy. The control group participants underwent the standard procedure. All participants filled out the VAS-P and VAS-A, and their vital signs were measured after the procedure. How satisfied the experimental group participants were with the VR application was also assessed after the procedure. Ethical Consideration: The study was approved by an ethics committee (Date: 31.07.2019 & No:44). Permission was obtained from the hospital (Date: 07.08.2019 & No: 28955). Patients were informed about the research purpose, procedure, and confidentiality prior to participation and that they could withdraw from the study at any time without any monetary concessions. Written consent was obtained from those who agreed to participate. Permission was obtained from the developer of the 360 degree VR video.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vital Signs, Anxiety, Colonoscopy
Keywords
Anxiety, colonoscopy, pain, virtual reality glasses, vital signs

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A randomized controlled trial
Masking
Outcomes Assessor
Masking Description
The data of the study were entered by a person other than the researcher. Statistical analysis was performed by a person other than the researcher. In the study, virtual reality glasses were worn on the participants of experimental group. For this reason, blinding could not be done for the participants. The researcher herself collected all data because the hospital restricted traffic in and out of the unit due to the pandemic. Therefore, the evaluator was not blinded to the study.
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
intervention
Arm Type
Experimental
Arm Description
This study was carried out with two groups. Virtual reality glasses were used for the intervention group.
Arm Title
control
Arm Type
No Intervention
Arm Description
No application was made to the control group, standard procedure was followed.
Intervention Type
Other
Intervention Name(s)
virtual reality glasses
Intervention Description
Virtual reality (VR) glasses have a detachable screen frame compatible with smartphones. A VR headset has earphones and sensors that track the user's head movements, giving them the impression that they are moving around in a virtual environment. The investigators used a smartphone and VR glasses to perform the intervention. They connected the phone to the VR headset via a 360 degree VR video app. Experimental participants wore the VR glasses and watched a 360 degree VR video of nature scenes with ambiance music during colonoscopy. They put on the VR glasses right before the procedure and took them off right afterward.
Primary Outcome Measure Information:
Title
blood pressure
Description
mmHg. higher scores mean a worse
Time Frame
Change in systolic blood pressure during colonoscopy, an average of 20 minutes
Title
pulse rate (heart rate)
Description
beats per minute. higher scores mean a worse
Time Frame
Change in pulse rate during colonoscopy, an average of 20 minutes
Title
respiratory rate
Description
respiratory rate per minute. higher scores mean a worse
Time Frame
Change in respiratory rate during colonoscopy, an average of 20 minutes
Title
peripheral oxygen saturation (SpO2)
Description
Approaching 100% is considered positive. higher scores mean a better
Time Frame
Change in peripheral oxygen saturation during colonoscopy, an average of 20 minutes
Title
Pain score
Description
Visual Analog Scale-Pain (VAS-P), which is a 10cm long line with anchor statements "0=no pain" at the left-most end and "10=unbearable pain" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better
Time Frame
Change in pain score during colonoscopy, an average of 20 minutes
Title
Anxiety score
Description
Visual Analog Scale-Anxiety (VAS-A), which is a 10 cm long horizontal line with anchor statements "0=no anxiety at all" at the left-most end and "10=worst anxiety imaginable" at the right-most end. minimum=0, maximum=10; higher scores mean a worse and lower scores mean a better
Time Frame
Change in anxiety score during colonoscopy, an average of 20 minutes

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
Research shows that gender affect pain and anxiety during colonoscopy. Therefore, we randomized participants into the groups, which were similar in terms of gender.
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Voluntary Scheduled for a colonoscopy without sedation Aged 18 to 79 years No perception, hearing, and vision impairment that interferes with communication Not wearing glasses No psychiatric disorder No migraine, vertigo, active nausea, vomiting, headache, etc. Exclusion Criteria: no Voluntary Scheduled for a colonoscopy with sedation not been Aged 18 to 79 years participants have been perception, hearing, and vision impairment that interferes with communication wearing glasses participants have psychiatric disorder participants have migraine, vertigo, active nausea, vomiting, headache, etc.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Esra DOĞAN YILMAZ RN, PhD, Research Assistant
Organizational Affiliation
Kırıkkale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kirikkale University
City
Kirikkale
ZIP/Postal Code
71450
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The confidentiality of the data used in the study will be protected.

Learn more about this trial

The Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing Colonoscopy

We'll reach out to this number within 24 hrs